Atlas Trials

A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer

Clinical trial NCT01656538 · COMPLETED

Trial details

NCT number
NCT01656538
Sponsor
Canadian Cancer Trials Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2013-02-20
Primary completion
2016-11-18
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.